A Phase 2 Study With MIP-1404 in Men With High-Risk PC Scheduled for RP and EPLND Compared to Histopathology
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
This was a multicenter, multi-reader, open-label, Phase 2 study assessing the safety and
performance characteristics of MIP 1404 imaging in the detection of prostate gland and pelvic
lymph node cancer. Comparative performance characteristics between MIP 1404 imaging and MRI
were also assessed, as judged by histopathology results.